NIKE, Inc.
MX ˙ BMV ˙ US6541061031
SecurityMX:NKE / NIKE, Inc.
InstitutionPhysicians Financial Services, Inc.
Latest Disclosed Ownership13,953 shares
Latest Disclosed Value $ 889
Physicians Financial Services, Inc. reports 12.67% decrease in ownership of NKE / NIKE, Inc.

On January 21, 2026 - Physicians Financial Services, Inc. filed a 13F-HR form disclosing ownership of 13,953 shares of NIKE, Inc. (MX:NKE) valued at $889 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 21, 2025 disclosing 15,978 shares of NIKE, Inc.. This represents a change in shares of -12.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-21 2025-12-31 13F Nike CL B 654106103 13,953 -2,025 -12.67 1 -100.00 0.2385
2025-10-21 2025-09-30 13F Nike CL B 654106103 15,978 51 0.32 1 0.00 0.3041
2025-08-14 2025-06-30 13F Nike CL B 654106103 15,927 -200 -1.24 1 0.00 0.3369
2025-05-07 2025-03-31 13F/A-1 Nike CL B 654106103 16,127 2,381 17.32 1 0.00 0.3256
2025-05-07 2025-03-31 13F Nike CL B 654106103 16,127 2,381 1 0.3256
2025-02-03 2024-12-31 13F Nike CL B 654106103 13,746 -1,219 -8.15 1 0.00 0.3158
2024-10-31 2024-09-30 13F Nike CL B 654106103 14,965 -462 -2.99 1 0.00 0.4114
2024-08-14 2024-06-30 13F Nike CL B 654106103 15,427 -750 -4.64 1 0.00 0.3782
2024-05-10 2024-03-31 13F Nike CL B 654106103 16,177 100 0.62 2 0.00 0.5352
2024-01-26 2023-12-31 13F Nike CL B 654106103 16,077 100 0.63 2 0.00 0.6613
2023-10-31 2023-09-30 13F Nike CL B 654106103 15,977 0 0.00 2 0.00 0.6252
2023-07-26 2023-06-30 13F Nike CL B 654106103 15,977 200 1.27 2 0.00 0.6922
2023-05-17 2023-03-31 13F Nike CL B 654106103 15,777 -100 -0.63 2 0.00 0.8182
2023-02-09 2022-12-31 13F Nike CL B 654106103 15,877 -300 -1.85 2 -99.93 0.8366
2022-10-19 2022-09-30 13F Nike CL B 654106103 16,177 -154 -0.94 1,345 -19.41 0.6500
2022-08-17 2022-06-30 13F Nike CL B 654106103 16,331 54 0.33 1,669 -23.79 0.7427
2022-04-22 2022-03-31 13F Nike CL B 654106103 16,277 18 0.11 2,190 -19.19 0.8361
2022-02-02 2021-12-31 13F Nike CL B 654106103 16,259 -400 -2.40 2,710 12.03 1.0022
2021-10-27 2021-09-30 13F Nike CL B 654106103 16,659 -100 -0.60 2,419 -6.57 0.9799
2021-07-27 2021-06-30 13F Nike CL B 654106103 16,759 147 0.88 2,589 17.26 1.0618
2021-05-21 2021-03-31 13F Nike CL B 654106103 16,612 750 4.73 2,208 -1.60 0.9461
2021-02-03 2020-12-31 13F Nike CL B 654106103 15,862 -1,400 -8.11 2,244 3.55 1.0832
2020-11-10 2020-09-30 13F Nike CL B 654106103 17,262 -192 -1.10 2,167 26.65 1.0817
2020-07-28 2020-06-30 13F Nike CL B 654106103 17,454 4,080 30.51 1,711 54.56 0.9456
2020-04-27 2020-03-31 13F Nike CL B 654106103 13,374 275 2.10 1,107 -16.58 0.7608
2020-02-12 2019-12-31 13F Nike CL B 654106103 13,099 100 0.77 1,327 8.68 0.7179
2019-11-14 2019-09-30 13F Nike CL B 654106103 12,999 1 0.01 1,221 11.92 0.6983
2019-08-12 2019-06-30 13F Nike CL B 654106103 12,998 200 1.56 1,091 1.21 0.6420
2019-04-12 2019-03-31 13F Nike CL B 654106103 12,798 0 0.00 1,078 13.59 0.6700
2019-01-22 2018-12-31 13F Nike CL B 654106103 12,798 52 0.41 949 -12.13 0.6898
2018-11-14 2018-09-30 13F Nike CL B 654106103 12,746 -150 -1.16 1,080 5.06 0.7423
2018-08-21 2018-06-30 13F Nike CL B 654106103 12,896 0 0.00 1,028 21.80 0.7699
2018-04-17 2018-03-31 13F Nike CL B 654106103 12,896 250 1.98 844 6.70 0.6700
2018-02-12 2017-12-31 13F Nike CL B 654106103 12,646 50 0.40 791 21.13 0.6035
2017-11-01 2017-09-30 13F Nike CL B 654106103 12,596 0 0.00 653 -12.11 0.5340
2017-07-31 2017-06-30 13F Nike CL B 654106103 12,596 -351 -2.71 743 2.91 0.6292
2017-04-26 2017-03-31 13F Nike CL B 654106103 12,947 1,400 12.12 722 12.11 0.6228
2017-01-17 2016-12-31 13F Nike CL B 654106103 11,547 -1,400 -10.81 644 -5.43 0.5286
2016-11-01 2016-09-30 13F Nike CL B 654106103 12,947 1,400 12.12 681 6.91 0.5678
2016-07-14 2016-06-30 13F Nike CL B 654106103 11,547 -599 -4.93 637 -14.73 0.5574
2016-04-26 2016-03-31 13F Nike CL B 654106103 12,146 -200 -1.62 747 -3.24 0.6758
2016-02-09 2015-12-31 13F Nike CL B 654106103 12,346 12,346 772 0.7131
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.